EUROSTAD prospective observational study: Baseline characteristics, atopic dermatitis severity, and patient-reported outcomes

Background: The European Prospective Observational Study in Patients Eligible for Systemic Immunosuppressive Therapy for Atopic Dermatitis (EUROSTAD) aims to describe characteristics of patients treated with systemic therapy for atopic dermatitis (AD) over time and their management in a real-world setting.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research